UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Molecular Basis and Rationale for the Use of Targeted Agents and Immunotherapy in Sinonasal Cancers

Esposito, A; Stucchi, E; Baronchelli, M; Di Mauro, P; Ferrari, M; Lorini, L; Gurizzan, C; ... Bossi, P; + view all (2022) Molecular Basis and Rationale for the Use of Targeted Agents and Immunotherapy in Sinonasal Cancers. Journal of Clinical Medicine , 11 (22) , Article 6787. 10.3390/jcm11226787. Green open access

[thumbnail of Molecular Basis and Rationale for the Use of Targeted Agents and Immunotherapy in Sinonasal Cancers.pdf]
Preview
PDF
Molecular Basis and Rationale for the Use of Targeted Agents and Immunotherapy in Sinonasal Cancers.pdf - Published Version

Download (376kB) | Preview

Abstract

Despite the progress of surgery, radiotherapy, and neoadjuvant chemotherapy, the prognosis for advanced sinonasal cancers (SNCs) remains poor. In the era of precision medicine, more research has been conducted on the molecular pathways and recurrent mutations of SNCs, with the aim of understanding carcinogenesis, helping with diagnosis, identifying prognostic factors, and finding potentially targetable mutations. In the treatment of SNC, immunotherapy is rarely used, and no targeted therapies have been approved, partly because these tumors are usually excluded from major clinical trials. Data on the efficacy of targeted agents and immune checkpoint inhibitors are scarce. Despite those issues, a tumor-agnostic treatment approach based on targeted drugs against a detected genetic mutation is growing in several settings and cancer subtypes, and could also be proposed for SNCs. Our work aims to provide an overview of the main molecular pathways altered in the different epithelial subtypes of sinonasal and skull base tumors, focusing on the possible actionable mutations for which potential target therapies are already approved in other cancer types.

Type: Article
Title: Molecular Basis and Rationale for the Use of Targeted Agents and Immunotherapy in Sinonasal Cancers
Location: Switzerland
Open access status: An open access version is available from UCL Discovery
DOI: 10.3390/jcm11226787
Publisher version: https://doi.org/10.3390/jcm11226787
Language: English
Additional information: © 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Keywords: biomarkers, immunotherapy, molecular, sinonasal cancers, target therapy
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Surgery and Interventional Sci
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Surgery and Interventional Sci > Department of Targeted Intervention
URI: https://discovery.ucl.ac.uk/id/eprint/10181846
Downloads since deposit
9Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item